Atlas Trials

Neoplasms Prostate

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neoplasms Prostate

RecordFirmDate
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer (NCT05241236)Urological Research Network, LLC2020-11-15
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947)Poseida Therapeutics, Inc.2020-02-28
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer (NCT02349139)Asana BioSciences2015-01-19
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy (NCT02153918)National Cancer Institute (NCI)2014-05-31
MRI/Ultrasound Fusion Guided Prostate Cryotherapy (NCT02381990)Urological Research Network, LLC2013-08-01
Sipuleucel-T Manufacturing Demonstration Study (NCT01477749)Dendreon2012-06-01
Korean Practice Patterns for Screening PCA(Prostate Cancer) (NCT01371513)GlaxoSmithKline2010-05-01
Economic Analyses of the REDUCE Trial (NCT01337258)GlaxoSmithKline2010-01-01
Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy (NCT02652000)Kantonsspital Graubuenden2009-10-01
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203)Roswell Park Cancer Institute2009-09-01
ARI103094-Follow-Up Study for REDUCE Study Subjects (NCT00883909)GlaxoSmithKline2009-04-09
ARTS - AVODART After Radical Therapy For Prostate Cancer Study (NCT00558363)GlaxoSmithKline2007-11-01
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy (NCT00470834)GlaxoSmithKline2007-05-01
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men (NCT00363311)GlaxoSmithKline2006-07-01
Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA (NCT00148928)GlaxoSmithKline2005-03-01
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk (NCT00056407)GlaxoSmithKline2003-03-01

Track Neoplasms Prostate automatically

Every clearance here is in the API, with alerts when new ones post.